AIMO, ALBERTO
AIMO, ALBERTO
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure"
2017-01-01 Passino, Claudio; Giannoni, Alberto; Aimo, Alberto; Mirizzi, Gianluca; Emdin, Michele
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients]
2016-01-01 Aspromonte, Nadia; Gulizia, Michele Massimo; Clerico, Aldo; Di Tano, Giuseppe; Emdin, Michele; Feola, Mauro; Iacoviello, Massimo; Latini, Roberto; Mortara, Andrea; Valle, Roberto; Misuraca, Gianfranco; Passino, Claudio; Masson, Serge; Aimo, Alberto; Ciaccio, Marcello; Migliardi, Marco
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets
2018-01-01 Vergaro, G.; Aimo, A.; Barison, A.; Emdin, M.
A simple echocardiographic score to rule out cardiac amyloidosis
2020-01-01 Aimo, A.; Chubuchny, V.; Vergaro, G.; Barison, A.; Nicol, M.; Cohen-Solal, A.; Castiglione, V.; Spini, V.; Giannoni, A.; Petersen, C.; Taddei, C.; Pasanisi, E.; Chacko, L.; Martone, R.; Knight, D.; Brown, J.; Martinez-Naharro, A.; Passino, C.; Fontana, M.; Emdin, M.
A simple echocardiographic score to rule out cardiac amyloidosis
2021-01-01 Aimo, A.; Chubuchny, V.; Vergaro, G.; Barison, A.; Nicol, M.; Cohen-Solal, A.; Castiglione, V.; Spini, V.; Giannoni, A.; Petersen, C.; Taddei, C.; Pasanisi, E.; Chacko, L.; Martone, R.; Knight, D.; Brown, J.; Martinez-Naharro, A.; Passino, C.; Fontana, M.; Emdin, M.
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure
2019-01-01 Aimo, A.; Januzzi, J. L.; Mueller, C.; Miro, O.; Pascual Figal, D. A.; Jacob, J.; Herrero-Puente, P.; Llorens, P.; Wussler, D.; Kozhuharov, N.; Sabti, Z.; Breidthardt, T.; Vergaro, G.; Ripoli, A.; Prontera, C.; Saccaro, L.; Passino, C.; Emdin, M.
Amiodarone as a possible therapy for coronavirus infection
2020-01-01 Aimo, A.; Baritussio, A.; Emdin, M.; Tascini, C.
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis
2021-01-01 Pucci, A.; Aimo, A.; Musetti, V.; Barison, A.; Vergaro, G.; Genovesi, D.; Giorgetti, A.; Masotti, S.; Arzilli, C.; Prontera, C.; Pastormerlo, L. E.; Coceani, M. A.; Ciardetti, M.; Martini, N.; Palmieri, C.; Passino, C.; Rapezzi, C.; Emdin, M.
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis
2022-01-01 Morfino, P.; Aimo, A.; Panichella, G.; Rapezzi, C.; Emdin, M.
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure
2017-01-01 Aspromonte, N.; Gulizia, M. M.; Clerico, A.; Di Tano, G.; Emdin, M.; Feola, M.; Iacoviello, M.; Latini, R.; Mortara, A.; Valle, R.; Misuraca, G.; Passino, C.; Masson, S.; Aimo, A.; Ciaccio, M.; Migliardi, M.
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC)
2021-01-01 Emdin, M.; Perfetto, F.; Aimo, A.; Vergaro, G.; Buda, G.; Cappelli, F.; Pieroni, M.; Grippo, G.; Sorini Dini, C.; Canale, M. L.; Olivotto, I.; Cameli, M.; Casolo, G.
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry
2017-01-01 Emdin, Michele; Aimo, Alberto; Passino, Claudio; Vergaro, Giuseppe
Aspirin and Prognosis in Heart Failure: A Question of Power
2018-01-01 Aimo, A.; Ripoli, A.; De Caterina, R.; Emdin, M.
Aspirin for primary cardiovascular prevention: Is there a need for risk stratification?
2019-01-01 Aimo, A.; De Caterina, R.
Aspirin for primary cardiovascular prevention: Why the wonder drug should not be precipitously dismissed
2020-01-01 Aimo, A.; De Caterina, R.
Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification
2020-01-01 Aimo, A.; de Caterina, R.
Aspirin Therapy for Primary Prevention: The Case for Continuing Prescribing to Patients at High Cardiovascular Risk-A Review
2020-01-01 De Caterina, R.; Aimo, A.; Ridker, P. M.
Assessing Cardiac Response to Patisiran by Changes in Extracellular Volume: Potential Issues
2021-01-01 Barison, A.; Aimo, A.; Emdin, M.
Atrial amyloidosis: mechanisms and clinical manifestations
2022-01-01 Vergaro, G.; Aimo, A.; Rapezzi, C.; Castiglione, V.; Fabiani, I.; Pucci, A.; Buda, G.; Passino, C.; Lupon, J.; Bayes-Genis, A.; Emdin, M.; Braunwald, E.
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease
2017-01-01 Giannoni, Alberto; Aimo, Alberto; Mancuso, Michelangelo; Piepoli, Massimo Francesco; Orsucci, Daniele; Aquaro, Giovanni Donato; Barison, Andrea; De Marchi, Daniele; Taddei, Claudia; Cameli, Matteo; Raglianti, Valentina; Siciliano, Gabriele; Passino, Claudio; Emdin, Michele
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" | 1-gen-2017 | Passino, Claudio; Giannoni, Alberto; Aimo, Alberto; Mirizzi, Gianluca; Emdin, Michele | |
| [ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] | 1-gen-2016 | Aspromonte, Nadia; Gulizia, Michele Massimo; Clerico, Aldo; Di Tano, Giuseppe; Emdin, Michele; Feola, Mauro; Iacoviello, Massimo; Latini, Roberto; Mortara, Andrea; Valle, Roberto; Misuraca, Gianfranco; Passino, Claudio; Masson, Serge; Aimo, Alberto; Ciaccio, Marcello; Migliardi, Marco | |
| A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets | 1-gen-2018 | Vergaro, G.; Aimo, A.; Barison, A.; Emdin, M. | |
| A simple echocardiographic score to rule out cardiac amyloidosis | 1-gen-2020 | Aimo, A.; Chubuchny, V.; Vergaro, G.; Barison, A.; Nicol, M.; Cohen-Solal, A.; Castiglione, V.; Spini, V.; Giannoni, A.; Petersen, C.; Taddei, C.; Pasanisi, E.; Chacko, L.; Martone, R.; Knight, D.; Brown, J.; Martinez-Naharro, A.; Passino, C.; Fontana, M.; Emdin, M. | |
| A simple echocardiographic score to rule out cardiac amyloidosis | 1-gen-2021 | Aimo, A.; Chubuchny, V.; Vergaro, G.; Barison, A.; Nicol, M.; Cohen-Solal, A.; Castiglione, V.; Spini, V.; Giannoni, A.; Petersen, C.; Taddei, C.; Pasanisi, E.; Chacko, L.; Martone, R.; Knight, D.; Brown, J.; Martinez-Naharro, A.; Passino, C.; Fontana, M.; Emdin, M. | |
| Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure | 1-gen-2019 | Aimo, A.; Januzzi, J. L.; Mueller, C.; Miro, O.; Pascual Figal, D. A.; Jacob, J.; Herrero-Puente, P.; Llorens, P.; Wussler, D.; Kozhuharov, N.; Sabti, Z.; Breidthardt, T.; Vergaro, G.; Ripoli, A.; Prontera, C.; Saccaro, L.; Passino, C.; Emdin, M. | |
| Amiodarone as a possible therapy for coronavirus infection | 1-gen-2020 | Aimo, A.; Baritussio, A.; Emdin, M.; Tascini, C. | |
| Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis | 1-gen-2021 | Pucci, A.; Aimo, A.; Musetti, V.; Barison, A.; Vergaro, G.; Genovesi, D.; Giorgetti, A.; Masotti, S.; Arzilli, C.; Prontera, C.; Pastormerlo, L. E.; Coceani, M. A.; Ciardetti, M.; Martini, N.; Palmieri, C.; Passino, C.; Rapezzi, C.; Emdin, M. | |
| Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis | 1-gen-2022 | Morfino, P.; Aimo, A.; Panichella, G.; Rapezzi, C.; Emdin, M. | |
| ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure | 1-gen-2017 | Aspromonte, N.; Gulizia, M. M.; Clerico, A.; Di Tano, G.; Emdin, M.; Feola, M.; Iacoviello, M.; Latini, R.; Mortara, A.; Valle, R.; Misuraca, G.; Passino, C.; Masson, S.; Aimo, A.; Ciaccio, M.; Migliardi, M. | |
| Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) | 1-gen-2021 | Emdin, M.; Perfetto, F.; Aimo, A.; Vergaro, G.; Buda, G.; Cappelli, F.; Pieroni, M.; Grippo, G.; Sorini Dini, C.; Canale, M. L.; Olivotto, I.; Cameli, M.; Casolo, G. | |
| Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry | 1-gen-2017 | Emdin, Michele; Aimo, Alberto; Passino, Claudio; Vergaro, Giuseppe | |
| Aspirin and Prognosis in Heart Failure: A Question of Power | 1-gen-2018 | Aimo, A.; Ripoli, A.; De Caterina, R.; Emdin, M. | |
| Aspirin for primary cardiovascular prevention: Is there a need for risk stratification? | 1-gen-2019 | Aimo, A.; De Caterina, R. | |
| Aspirin for primary cardiovascular prevention: Why the wonder drug should not be precipitously dismissed | 1-gen-2020 | Aimo, A.; De Caterina, R. | |
| Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification | 1-gen-2020 | Aimo, A.; de Caterina, R. | |
| Aspirin Therapy for Primary Prevention: The Case for Continuing Prescribing to Patients at High Cardiovascular Risk-A Review | 1-gen-2020 | De Caterina, R.; Aimo, A.; Ridker, P. M. | |
| Assessing Cardiac Response to Patisiran by Changes in Extracellular Volume: Potential Issues | 1-gen-2021 | Barison, A.; Aimo, A.; Emdin, M. | |
| Atrial amyloidosis: mechanisms and clinical manifestations | 1-gen-2022 | Vergaro, G.; Aimo, A.; Rapezzi, C.; Castiglione, V.; Fabiani, I.; Pucci, A.; Buda, G.; Passino, C.; Lupon, J.; Bayes-Genis, A.; Emdin, M.; Braunwald, E. | |
| Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease | 1-gen-2017 | Giannoni, Alberto; Aimo, Alberto; Mancuso, Michelangelo; Piepoli, Massimo Francesco; Orsucci, Daniele; Aquaro, Giovanni Donato; Barison, Andrea; De Marchi, Daniele; Taddei, Claudia; Cameli, Matteo; Raglianti, Valentina; Siciliano, Gabriele; Passino, Claudio; Emdin, Michele |